Neurotensin Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neurotensin neurons are peptidergic neurons that utilize neurotensin as their primary neuromodulatory neuropeptide. These neurons are widely distributed throughout the central nervous system and play diverse roles in thermoregulation, pain modulation, reward processing, and energy homeostasis.
| Property |
Value |
| Category |
Peptidergic Neurons |
| Location |
Hypothalamus (preoptic area, paraventricular nucleus), Striatum (Nucleus accumbens), Central gray, Bed nucleus of the stria terminalis |
| Cell Types |
Neurotensin-expressing interneurons and projection neurons |
| Primary Neurotransmitter |
Neurotensin (13-amino acid peptide) |
| Key Markers |
NTS (neurotensin gene), NTSR1 (NTS receptor 1), NTSR2, NTSR3 |
| Co-transmitters |
GABA, glutamate in some populations |
Neurotensin neurons are found in several brain regions:
-
Hypothalamus
- Preoptic area: Thermoregulation
- Paraventricular nucleus: Stress response
- Arcuate nucleus: Energy balance
-
Striatum
- Nucleus accumbens shell: Reward
- Caudate/putamen: Motor modulation
-
Brainstem
- Periaqueductal gray: Pain modulation
- Solitary nucleus: Visceral integration
-
Limbic structures
- Bed nucleus of the stria terminalis: Anxiety
- Amygdala: Emotional processing
- Cell size: Medium (15-25 μm)
- Dendritic pattern: Multipolar with aspiny dendritic shafts in striatum
- Axonal projections: Extensive local collaterals and long-range projections
| Receptor |
Type |
Distribution |
Function |
| NTSR1 |
GPCR (Gs/Gq) |
Hypothalamus, VTA, NAc |
Thermoregulation, reward |
| NTSR2 |
GPCR (Gi) |
Brainstem, cortex |
Pain modulation |
| NTSR3/Sortilin |
Non-GPCR |
Ubiquitous |
Neurodevelopment |
- NTSR1: Increases intracellular Ca²⁺, activates PKC, modulates dopamine signaling
- NTSR2: Inhibits adenylate cyclase
- NTSR3: Participates in protein trafficking
-
Thermoregulation
- Warm-sensitive neurons in preoptic area
- Promote heat loss behaviors
- Counteract orexin-mediated thermogenesis
-
Pain Modulation
- Analgesic effects via periaqueductal gray
- Interaction with endogenous opioid systems
- Modulation of nociceptive transmission
-
Reward Processing
- Dopamine release in nucleus accumbens
- Enhancement of reward learning
- Interaction with mesolimbic pathway
- Psychostimulant effects
-
Energy Balance
- Suppression of food intake
- Interaction with leptin signaling
- Modulation of metabolism
-
Additional Roles
- Anxiety and stress response
- Hydro-osmoregulation
- Gastrointestinal motility
- Temperature sensors (via preoptic area)
- Pain afferents (via brainstem)
- Limbic inputs (amygdala, hippocampus)
- Metabolic signals (leptin, ghrelin)
- Ventral tegmental area: Reward modulation
- Nucleus accumbens: Motivation
- Hypothalamus: Autonomic control
- Periaqueductal gray: Pain control
- Nigrostriatal system: Neurotensin interacts with dopaminergic neurons in substantia nigra
- Reward processing: Dysregulated reward circuits contribute to anhedonia
- Thermoregulation: Impaired temperature control in PD
- Therapeutic target: NTSR1 agonists being explored
- Cognitive changes: Neurotensin may modulate learning and memory
- Neurotensin deficits: Reported in AD brains
- Interaction with amyloid: NTS processing altered in AD
- Potential therapy: Neurotensin analogs under investigation
- Huntington's disease: Altered neurotensin signaling
- ALS: Neurotensin as potential biomarker
- Multiple system atrophy: Autonomic dysfunction connections
-
NTSR1 Agonists
- Thermal dysregulation in PD
- Cognitive enhancement
- Analgesic potential
-
NTSR1 Antagonists
- Psychosis treatment (similar to antipsychotics)
- Anti-reward in addiction
- Neurotensin as neurotransmitter marker
- Circuit mapping of reward pathways
- Thermoregulation studies
The study of Neurotensin Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Carraway RE, Leeman SE. The isolation of a new hypotensive peptide, neurotensin. Ann N Y Acad Sci. 1982;400:95-111.
[2] St-Pierre SA, Kérouac R. Neurotensin. Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(4):565-572.
[3] Binder EB, Kinkead B. Neurotensin and dopamine interactions. Peptides. 2006;27(10):2365-2374.
[4] Dobner PR. Neurotensin and pain modulation. Pain. 2006;121(1-2):1-3.
[5] Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896-912.
[6] Lemstra AW, et al. Neurotensin in Alzheimer's disease. J Neural Transm. 2007;114(8):1053-1057.